Agappe Diagnostics Limited

We are an ISO 9001- 2008 and ISO 13485:2003 certified Company. We conform to GMP standards and have an FDA approved most modern manufacturing facility spread over 60000 sq.ft. of built up area. We have been successful in obtaining CE Marking as well for our products.

Manufacturing and Testing We ensure the best in quality, technology and processes to our customers by FDA approved quality control labs, designed to analyze raw materials as well as finished products with the same stringent standards. With dedicated scientists & production staff and modern equipments, our overall manufacturing capabilities are of international standards. Since its foundation in 1994, Agappe has always based its activity on in-house research and know-how, utilizing a wide skill base to gain best results in terms of quality and performance. We give priority to high quality standards in each individual sector of the working process, whether it is in terms of production or quality assurance. Each phase of manufacturing cycle is subjected to strict quality control: from raw materials up to final product testing. The unique flexible production technology provides adaptability in production capacity which can be quickly adjusted to meet scientific and operational requirements.

News & Events
Exhibited in : AACC 2011, USA
AACC 2011 – Georgia World Congress Center, 26 - 28th July 2011, Stall No: 3573 and 3575, Atlanta, USA.
Agappe Ties up with Kyowa Medex of Japan
Agappe has entered in to a collaborative agreement with Kyowa Medex Co. Ltd., Japan by which Kyowa Medex will supply HDL and LDL to Agappe on a long term basis. The agreement was signed on Friday, May 27th, 2011 by Mr. Masahito Yamaguchi, President and CEO of Kyowa Medex and Mr. Thomas John, Managing Director, Agappe in the presence of a number of high ranking officials from Kyowa Medex. Kyowa Medex is one of the world largest manufacturers of HDL and LDL and this association will benefit the customers in India due to highly quality products and competitive prices. Kyowa Medex has known for its excellent quality of Specialty Reagents and according to Kyowa Medex, this association with Agappe is a significant step in expanding their market presence in India which is one of the fastest growing economies in the world offering vast opportunities. Agappe’s brand equity in India and their reputation in offering top quality products and well established marketing network will undoubtedly help us achieving our goal as far as the market in India is concerned. Mr. Thomas John added that Agappe has such tie-ups with a number of Japanese Manufacturers in different field and this business cooperation with Kyowa Medex is yet another step in sourcing the right product mix for the benefit of the customers in India. He was upbeat on the prospect of growing Agappe’s relations with Kyowa Medex in a significant way in the coming years. Mr. John is confident that with this business cooperation with Kyowa Medex, Agappe will be able to cater to all types of Labs in India and make this product portfolio a great success.
Exhibited in IFCC WORLD LAB 2011- Germany
IFCC WORLD LAB - Berlin, 16 - 18th May 2011, Booth, Hall No. 17, Booth # 06.
Exhibited in AFRICA HEALTH 2011 – South Africa
AFRICA HEALTH 2011 – Johannesberg Expo centre, South Africa, 9 - 11th May 2011, Stall # B-8 at MEDLAB section.
Mr. Chandrasekaran Venkatraman (Chandu), Chief Operating Officer.
Mr. Chandrasekaran has over 28 years of experience in the banking sector having worked with Indian and Multi-national banking corporations in senior positions. He will be in-charge of the entire operations of the organization except Sales & Marketing.

Agappe has grown over the years as one of the Leading Diagnostic Reagents Manufacturers in India. Our world class most modern state-of-the-art manufacturing facilities are one of the largest and best in India in the industry. The Corporate Office and Factory is spread over an area of 200000 sq.ft. and it haws a built up area of over 80,000 sq.ft. which is capable of taking care of its ever increasing market penetration, be it in India or abroad.

Vision
To Establish Globally As A Premier In-Vitro Diagnostic Corporation And To Be The Best Partner In The Diagnostic Field For The Welfare Of Mankind.

Mission
To Expand And Continuously Improve Our Products And Services With A World Class R&D Program And To Provide The Best Work Environment For Our Employees To Meet And Exceed Their True Potential And To Thrive In A World Of Excellence.

Agappe in Greek means ‘Divine Love’. And it is with this devotion that we deliver all our products and services. Fully computerized systems, dedicated scientists, end user training, foolproof delivery systems, excellent technical support etc set us apart from the competition.